Skip to main content
. 2010 Jan 20;101(5):1300–1308. doi: 10.1111/j.1349-7006.2010.01506.x

Figure 1.

Figure 1

 Matrix metalloproteinase 7 (MMP‐7) gene expression, serum concentration, and metastasis. (A) Patients with non‐metastatic urinary bladder cancer (UBC) and no metastasis in follow‐up; (B) patients with lymph node‐positive tumors (at surgery); (C) patients with lymph node‐negative tumor but metastasis in a 24‐month follow‐up period; (D) patients with lymph node‐negative cancer but metastasis more than 24 months after surgery. MMP‐7 gene expression and serum concentration is the highest in patients with present metastasis (B) and in patients with metastasis in a 24‐month follow‐up period (C). In contrast, MMP‐7 gene expression and serum concentration is lower in patients without present or later metastasis (A) and in those with a history of metastasis more than 24 months after surgery (D).